BRCA2 and hypoparathyroidism-retardation-dysmorphism syndrome: Molecular analysis of 5540 EC demonstrated that HRD may be present with a frequency of 34% with ARID1A, ATM, and BRCA2 mutations detected in 27%, 4.6%, and 3.05%, respectively [38].